Skip Navigation

Phase I Study in Metastatic Solid Tumor Malignancies with KRAS G12D Mutation ASP3082 Parexel 267236

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT05382559

Study #:
STUDY00148965

Start Date:
Aug 31, 2022

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05382559

View Complete Trial Details & Eligibility at ClinicalTrials.gov